GlaxoSmithKline PLC
OTC:GLAXF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GlaxoSmithKline PLC
OTC:GLAXF
|
UK |
|
Elbit Systems Ltd
NASDAQ:ESLT
|
IL |
|
N
|
NanoString Technologies Inc
F:0F1
|
US |
|
C
|
Capital Power Corp
F:2CP
|
CA |
|
S
|
Software AG
DUS:SOW
|
DE |
|
H
|
Helen of Troy Ltd
F:HT2
|
BM |
|
I
|
International Game Technology PLC
XBER:7IG
|
UK |
Wall St Price Targets
GLAXF Price Targets Summary
GlaxoSmithKline PLC
According to Wall Street analysts, the average 1-year price target for GLAXF is 28 USD with a low forecast of 19.58 USD and a high forecast of 38.46 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GLAXF's stock price target?
Price Target
28
USD
According to Wall Street analysts, the average 1-year price target for GLAXF is 28 USD with a low forecast of 19.58 USD and a high forecast of 38.46 USD.
What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 4%.
